Ohio Tepezza lawsuits have been gaining attention as more individuals come forward with claims of permanent hearing loss and tinnitus after receiving treatment for thyroid eye disease. These class action lawsuits allege that Horizon Therapeutics, the manufacturer of Tepezza, failed to adequately warn patients and physicians about the risks of permanent hearing damage.
As the legal landscape evolves, it’s crucial to stay informed about the latest developments, potential settlements, and eligibility criteria in these cases.
If you or someone you care about has experienced Tepezza-related complications, particularly permanent hearing loss, the committed team at Schmidt & Clark, LLP is ready to assist. As a nationally acclaimed law firm with a specialization in plaintiff cases, our main goal is to secure the justice and compensation you rightfully merit.
Table Of Contents
Ohio Tepezza Lawsuits
A growing number of Ohio Tepezza hearing loss lawsuits have been filed against Horizon Therapeutics, alleging the company’s negligence in providing sufficient warning about the risk of hearing loss tied to Tepezza treatment.
The number of Ohio Tepezza lawsuits has increased significantly in recent months, with many cases being consolidated into multidistrict litigation (MDL) for more efficient pretrial proceedings.
Status conferences have been scheduled to discuss the progress of these cases in both state and federal courts. With the escalating number of Tepezza hearing loss lawsuits, those affected must stay aware of their legal rights and options.
Plaintiffs’ Claims and Horizon’s Defense
Plaintiffs in Ohio Tepezza lawsuits argue that Horizon Therapeutics failed to provide adequate warnings about the potential for hearing loss and tinnitus associated with the treatment. They claim that the company promoted Tepezza as a first-line treatment for thyroid eye disease despite the European Group on Graves Orbitopathy recommending it as a second-line treatment.
Additionally, plaintiffs assert that Horizon did not advise physicians to conduct hearing tests during treatment, which could have allowed for earlier detection of hearing damage and potentially limited the harm.
On the other hand, Horizon Therapeutics maintains that the FDA-approved label for Tepezza included sufficient information about the risks of hearing loss and tinnitus. They have filed motions to dismiss the Tepezza hearing loss claims, citing the federal preemption doctrine as grounds for dismissal.
Yet, this defense might not stand in court given that drug manufacturers are permitted to modify their warning labels without FDA approval if new risk evidence emerges.
Recent Ohio Tepezza Lawsuit Developments
Several notable developments have transpired as Ohio Tepezza lawsuits keep progressing. The developments include:
- The number of pending cases has increased.
- Many cases have been consolidated into multidistrict litigation (MDL) in one district court to streamline pretrial proceedings.
- Both state and federal courts have scheduled status conferences to deliberate on the cases’ progress.
A recent case study from Stanford University has also added weight to the plaintiffs’ claims, finding a link between hearing loss and dosage levels of Tepezza injections. This new evidence could bolster the arguments made by plaintiffs in these lawsuits, further highlighting the importance of staying informed about the latest developments in Ohio Tepezza litigation.
What Is Tepezza?
Tepezza is a prescription medication that was created as a thyroid eye disease treatment specifically to treat thyroid eye disease (TED) [1]. This rare autoimmune disorder causes muscles and tissues around the eyes to be affected.
It is the first and only FDA-approved treatment for this condition, which can cause symptoms such as:
- bulging eyes
- double vision
- pain
- vision loss due to damage to the optic nerve
Tepezza has offered hope to many individuals suffering from TED, as it can help alleviate the painful and debilitating symptoms associated with the disease.
Despite Tepezza’s benefits, concerns related to the treatment’s potential side effects have emerged. In particular, a growing number of patients have reported experiencing hearing loss and tinnitus after receiving Tepezza infusions, prompting the filing of numerous Tepezza hearing loss lawsuits against Horizon Therapeutics.
Tepezza Side Effects & Hearing Loss
While Tepezza has proven effective in treating thyroid eye disease, it has also been linked to hearing loss, including sensorineural hearing loss and tinnitus in some patients. These hearing-related side effects can range from mild to severe, with some individuals experiencing permanent hearing impairment or even deafness.
The FDA has updated the warning label for Tepezza to acknowledge the risk of hearing loss, further emphasizing the importance of being aware of these potential side effects.
Closely monitoring patients receiving Tepezza infusions and conducting regular hearing tests throughout the treatment can help medical professionals minimize hearing damage risk.
Patients should also be proactive in discussing any hearing concerns with their healthcare team and seeking appropriate medical evaluations if necessary.
Does Tepezza Cause Hearing Problems?
Tepezza does cause hearing problems. Some research indicates that Tepezza may be linked to hearing loss and tinnitus in some patients, though the exact cause of these side effects remains unclear [2].
A study conducted by Stanford University found that the risk of hearing loss increased with higher dosage levels and longer treatment durations, suggesting a possible connection between Tepezza and hearing problems.
Patients undergoing Tepezza infusions should be aware of potential hearing-related side effects and promptly convey any concerns to their healthcare team. By closely monitoring patients’ hearing acuity and conducting regular tests, medical professionals can help to identify and address any hearing issues that may arise during treatment.
65% of individuals who used Tepezza experienced some degree of hearing loss, hearing damage, or tinnitus. – The Endocrine Society Journal
Despite the concern of patients and healthcare providers about the risk of hearing loss and tinnitus associated with Tepezza, weighing the potential benefits against the possible side effects is critical.
For many individuals suffering from thyroid eye disease, Tepezza can offer significant relief from painful and debilitating symptoms. However, being informed about the potential risks and working closely with a knowledgeable medical team can help patients make the best decision for their unique circumstances.
Potential Settlements and Compensation in Ohio Tepezza Lawsuits
The potential settlement amounts in Tepezza lawsuits can vary depending on factors such as the patient’s age, preexisting hearing issues, and the severity of the hearing loss experienced as a result of the treatment.
Current estimates suggest that compensation for Ohio Tepezza lawsuits may range from $140,000 to $350,000, depending on the specific circumstances of each case.
It’s worth noting that each Tepezza lawsuit is unique, and settlement amounts can vary based on individual case specifics and circumstances. For those affected by hearing loss or tinnitus after receiving Tepezza infusions, it is crucial to consult with an experienced attorney to evaluate their case and discuss the potential for compensation.
Who Qualifies to File an Ohio Tepezza Lawsuit?
An individual who has been prescribed Tepezza for thyroid eye disease treatment received two infusions and suffered hearing loss or tinnitus as a result of the treatment qualifies to file an Ohio Tepezza lawsuit.
If you meet these criteria, you may qualify to file a Tepezza lawsuit against Horizon Therapeutics. Consultation with an experienced attorney is advisable if you believe you might be eligible to file a Tepezza lawsuit, as they can help guide you through the legal process.
Filing an Ohio Tepezza Hearing Loss Lawsuit
The process of filing a Tepezza hearing loss lawsuit in Ohio can be complex and challenging. It is essential to work with an experienced attorney who can help navigate the legal system and secure the best possible outcome for your case.
A skilled legal team can provide valuable guidance and support throughout the process, ensuring that your rights are protected and that you receive the compensation you deserve.
Beyond providing legal representation, Tepezza lawyers can aid in preparing your case, gathering evidence, and negotiating settlements on your behalf. By working closely with a knowledgeable attorney, you can focus on your recovery while your legal team handles the intricacies of your case.
FAQs
Who can file a Tepezza lawsuit in Ohio?
Individuals who have experienced severe side effects or complications after using Tepezza may be eligible. Consult a lawyer to discuss your specific case.
What compensation might I receive from a Tepezza lawsuit?
Compensation may cover medical expenses, lost wages, pain and suffering, and other related damages. Each case varies based on individual circumstances.
Can I join a Tepezza lawsuit if I used it years ago?
Yes, you may still be eligible to file a lawsuit depending on the statute of limitations and your diagnosis timeline. Consult a lawyer to evaluate your case.
See all related dangerous drugs lawsuits our attorneys covered so far.
Get Your Free Case Evaluation From Ohio Tepezza Lawyers
Schmidt and Clark, LLP are here to provide unwavering support during your time of need. If you or a loved one has encountered complications related to Tepezza, please reach out to us without hesitation.
Our team has extensive experience in handling such cases and will be there to support you throughout the entire process. You deserve to be well-informed about your legal rights and the potential eligibility for a lawsuit.
Be assured you will receive a free consultation, and you won’t have any financial obligations unless we secure a favorable outcome for your case. Get in touch with Schmidt and Clark today for a comprehensive case evaluation. Let us be your trusted partner on this legal journey.
Reference:
- https://www.tepezza.com/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058351/